JPRN-jRCTs051200109进行中（未招募）未知
A multicenter, open-label, prospective study of durvalumab, etoposide, and carboplatin for unresectable small cell lung cancer with mild idiopathic interstitial pneumonia - DREAM study
Fujimoto Daichi0 个研究点目标入组 22 人开始时间: 2021年1月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Key inclusion criteria are as follows: 1) patients who have unresectable extensive disease, 2) patients whose tumor is histologically or cytologically confirmed small cell lung cancer, 3) patients aged >=20 years, 4) patients with Eastern Cooperative Oncology Group performance status of 0 to 1, 5) patients have no previous chemotherapy or immune checkpoint inhibitor for small cell lung cancer, 6) patients with chronic fibrotic IP, 7) patients diagnosed as Probable UIP pattern, Indeterminate for UIP pattern, and Alternative diagnosis pattern according to the ATS/ERS/JRS/LATS association official guidelines, and 8) patients with adequate organ function.
排除标准
- •Key exclusion criteria are as follows: 1) any history of previous malignancy in the past 5 years, 2) any history of autoimmune disease (patients who have controlled thyroid dysfunction or skin disease that does not require systemic therapy eligible), 3) %VC <80%, 4) patients diagnosed as definite UIP pattern, 5) other interstitial lung disease including connective tissue disease-ILD, pneumoconiosis, and drug-induced pneumonitis, 6) history of taking corticosteroid, other immunosuppressive drug, pirfenidone, and nintedanib within 14 days before registration, and 7) patients with symptomatic brain metastasis or meningeal carcinomatosis.
研究者
相似试验
进行中（未招募）
1 期
A clinical study to evaluate the efficacy and potential side effects of intravenous PDNO (that releases nitric oxide into the blood stream) in patients with high blood pressure in the lung circulation after heart surgeryAcute Pulmonary HypertensionMedDRA version: 20.0Level: HLTClassification code 10037401Term: Pulmonary hypertensionsSystem Organ Class: 100000004855EUCTR2021-005032-30-SEAttgeno AB40
进行中（未招募）
3 期
An Open-Label, Multicentre Study to Evaluate the Duration of Clinical Remission of Two Courses of Weekly Intramuscular administration of AMEVIVE (alefacept) by evaluating the time to retreatment with AMEVIVE or an alternative systemic therapy in patients with chronic plaque psoriasis in the context of standard dermatological practiceChronic plaque psoriasisSkin - Dermatological conditionsACTRN12605000295640Biogen Idec100
进行中（未招募）
1 期
A clinical trial to compare the occurrence (or incidence) of the most common fair skin cancer in solid organ transplant recipients (squamous cell carcinoma) and its preliminary stage (actinic keratoses) in two different groups: One group is treated with a fixed combination of a cream followed by exposure to red light and the other group receives liquid nitrogen (cryotherapy) as lesion-directed therapy.Squamous Cell Carcinoma and Actinic Keratoses in solid organ transplant recipientsMedDRA version: 14.1Level: PTClassification code 10000614Term: Actinic keratosisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2012-004111-32-DECharité Universitätsmedizin Berlin70
已完成
1 期
Study of safety and efficacy of DKY709 alone or in combination with PDR001 in patients with advanced solid tumorsJPRN-jRCT2080224700ovartis Pharma. K.K.380
已完成
4 期
OsteoArthritis Synvisc-One (Hylan G-F 20) Indian Post Marketing Study (OASIS)CTRI/2010/091/000052Genzyme India Pvt. Ltd.400